Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4331066 | 4121302 | I | 4331066-5 | 20030901 | 20040322 | 20040331 | EXP | 163-20785-04030550 | CELGENE CORPORATION WWDSS | 62 | YR | M | N | 20040322 | MD | 20030901 |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4331066 | 1004758864 | PS | THALOMID | 1 | ORAL | 400 MG, QD, ORAL | D | D | 0121U | 20050401 | 20785 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4331066 | 1004758864 | RENAL CELL CARCINOMA STAGE UNSPECIFIED |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4331066 | DE |
Reactions reported
| Event ID | PT |
|---|---|
| 4331066 | MALIGNANT NEOPLASM PROGRESSION |
| 4331066 | RENAL CELL CARCINOMA STAGE UNSPECIFIED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4331066 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4331066 | 1004758864 | 20011214 |